PayPal is buying Paydiant, a startup that provides the mobile payments and loyalty technology used by many big-name retailers use in their apps, for an undisclosed amount. PayPal also announced on… Read more »
If you ever wondered what happened to the algae fuel work between Synthetic Genomics and Exxon — it was scaled back and now is focused on long term research instead of… Read more »
The US presidential election was further proof that 2012 has been a good year to be a quant — and being a data scientist has never been sexier. But data is… Read more »
Obama’s 2013 budget proposal is out and aside from some increases in support for many of the renewable energy programs the DOE administers, like the Advanced Research Projects Agency-Energy (ARPA-E) and… Read more »
Following Apple’s announcement of record revenue and profit for its first financial quarter of 2012, its stock is surging in after hours trading. Share value has climbed to around $452, or… Read more »
One of the difficulties with investing in early-stage cleantech startups is that oftentimes the investors need to take a very long-term view of the companies they back: Many startups won’t mature… Read more »
At midnight on New Year’s Day the Department of the Treasury’s Section 1603 cash grants program expired, dashing the hopes of those who have expressed legitimate concern that the end of… Read more »
Looks like Groupon will go public on Friday morning at $20 per share, giving it a valuation of $12.6 billion for its online coupon business. Let’s compare it to some of… Read more »
Genomics guru Craig Venter and his startup Synthetic Genomics might be hitting some hurdles with their partnership with Exxon, but on Monday the company announced that it will create a joint… Read more »